medline.ch Onkologie Urologische Tumoren

	EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naÃ¯ve metastatic hormone-sensitive prostate cancer. Oncologist Jang A, Fowler P, Helminiak K, Kumar HLS, Pasucal J, Delong V, Zhong JY, Jindal T, Grier AL, Patel RR, Hislop M, Cesano A, Villaluna K, Younginger B, Wolff K, Richey K, Bray J, Garcia H, Adamowicz T, Reese A, Nizam A, Gupta S, Wee CE, Margevicius S, Fu P, Mendiratta P, Sheng IY, Brown JR, Garcia JA, Barata PC. PMID: 41467749 [PubMed - as supplied by publisher]
	Five things you need to know about prostate cancer diagnostic tests. Asian J Urol Vickers AJ, Lilja H. PMID: 41467205 [PubMed]
	Opportunistic salpingectomy during radical cystectomy for bladder cancer: A systematic review of the literature. Asian J Urol Cerrato C, Pandolfo SD, Kraft P, Ko DSC, Mir MC. PMID: 41467203 [PubMed]
	Prostate cancer screening. Asian J Urol España Navarro R, González-Padilla DA, Subiela JD, Pérez-Serrano C, Olmos D, Carlsson SV. PMID: 41467195 [PubMed]
	Clinically lymph node-positive urothelial bladder cancer treated with upfront radical cystectomy: Diagnostic accuracy of MRI and long-term oncologic outcomes. Asian J Urol Laymon M, Elsawy AA, Elsorougy A, Hashem A, Mosbah A, Abol-Enein H, Mansour I, El-Hefnawy AS. PMID: 41467194 [PubMed]
	Advancements in artificial intelligence for prostate cancer: Optimizing diagnosis, treatment, and prognostic assessment. Asian J Urol Arita Y, Roest C, Kwee TC, Paudyal R, Lema-Dopico A, Fransen S, Hirahara D, Takaya E, Ueda R, Ruby L, Nissan N, Schwartz LH, Shukla-Dave A, Akin O. PMID: 41467190 [PubMed]
	Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI). Clin Transl Radiat Oncol Raynaud C, Nebbache R, Belkacemi Y, Chargari C, Durdux C, Hennequin C, Huguet F, Quero L, Bibault JE. PMID: 41467108 [PubMed]
	Two-fraction Ultrahypofractionated Radiotherapy with focal BOost for intermediate-risk, localized prostate cancer (TURBO): study protocol of a phase II, randomized controlled clinical trial. Trials Lalmahomed TA, Monninkhof EM, van Rijssel MJ, van Melick HHE, Verkooijen HM, de Boer JCJ, van der Voort van Zyp JRN. PMID: 41466435 [PubMed - indexed for MEDLINE]
	CT-based AI score associates with perioperative outcomes in nephron-sparing surgery for renal cell carcinoma. Cancer Imaging Shengfa L, Liqing S, Shu C, Huijian C, Yuying L, Zijie L, Yinfeng X, Qianwen L, Zhuting F, Mingping M, Minxiong H. PMID: 41466327 [PubMed - indexed for MEDLINE]
	Retroperitoneal hibernoma mimicking a metastatic germ cell tumor: a case report and review of the literature. J Med Case Rep Ben Rejeb S, Aloui M, Kouki N, Ben Romdhane Y, Rachdi H, Khouni H. PMID: 41466320 [PubMed - indexed for MEDLINE]
	Low-grade oncocytic tumor of kidney: A case report. Medicine (Baltimore) Kang TS, Chen YZ. PMID: 41465906 [PubMed - indexed for MEDLINE]
	A multiomics analysis-assisted machine learning model identifies renal hamartoma without visible fat and homogeneous clear cell renal cell carcinoma: A retrospective cohort study. Medicine (Baltimore) Wu Y, Lu K, Liao Y, Wang J, Yang T, Wang L, Li F. PMID: 41465898 [PubMed - indexed for MEDLINE]
	Significance of EVs in Prostate Cancer Bone Metastases. Int J Mol Sci Ito K, Tamura T, Urabe F, Sakamoto S, Kimura T, Egawa S, Ochiya T. PMID: 41465584 [PubMed - indexed for MEDLINE]
	The Role of Natural Chalcones and Their Derivatives in Targeting Prostate Cancer: Recent Updates. Int J Mol Sci Hussein OJ, Elkhalifa D, Hassan AF, Alali F, Al Moustafa AE, Khalil A. PMID: 41465509 [PubMed - indexed for MEDLINE]
	Immune Landscape and Application of Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma. Int J Mol Sci An Y, Luo N. PMID: 41465413 [PubMed - indexed for MEDLINE]
	IL-12 as a Potential Prognostic Marker in Penile Cancer: Implications for Immune Dysregulation. Int J Mol Sci Czajkowski M, Kunc M, Kie, Krazi, Matuszewski M, , Hakenberg OW, Wierzbicki PM. PMID: 41465261 [PubMed - indexed for MEDLINE]
	Pathogenesis-Guided Biomarker Assessment: A Shift in Prostate Cancer Diagnostics. Int J Mol Sci Logan JM, Malone V, O'Leary JJ, Brooks DA. PMID: 41465218 [PubMed - indexed for MEDLINE]
	Exercise, APOE Genotype, and Testosterone Modulate Gut Microbiome-Cognition Associations in Prostate Cancer Survivors. Genes (Basel) Raber J, O'Niel A, Kasschau KD, Pederson A, Robinson N, Guidarelli C, Chalmers C, Winters-Stone K, Sharpton TJ. PMID: 41465180 [PubMed - indexed for MEDLINE]
	Molecular Cargo of Exosomes in Prostate Cancer: A Multi-Omics Perspective on Liquid Biopsies. Genes (Basel) Coman RA, Nutu A, Strilciuc S, Budisan L, Berindan-Neagoe I. PMID: 41465110 [PubMed - indexed for MEDLINE]
	The Role of Untraceable Sentinel Lymph Nodes in Prostate Cancer Patients Undergoing Radical Prostatectomy and Pelvic Lymph Node Dissection: Insights from an Ongoing Prospective Study. J Clin Med Venclovas Z, Vajauskas D, Jarusevicius P, Sasnauskas G, Ruzgas T, Jievaltas M, Milonas D. PMID: 41464757 [PubMed]

Artikel 1 - 20 / 174894

Seite 1 von 8745

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung